Substance Abuse and Mental Health Services Administration. Results from the 2024 National Survey on Drug Use and Health. SAMHSA.
University of North Carolina School of Medicine. Results from the 2021 to 2024 National Surveys on Drug Use and Health. UNC School of Medicine.
Substance Abuse and Mental Health Services Administration. (August 9, 2025). 2024 National Survey on Drug Use and Health (NSDUH) Releases. SAMHSA.
Substance Abuse and Mental Health Services Administration. (July 28, 2025). SAMHSA Releases Annual National Survey on Drug Use and Health. SAMHSA.
Office of Disease Prevention and Health Promotion. National Survey on Drug Use and Health (NSDUH). U.S. Department of Health and Human Services.
JAMA Network Open. (December 7, 2023). Opioid Prescribing by US Surgeons, 2016-2022. JAMA Network Open.
Agency for Healthcare Research and Quality. STATISTICAL BRIEF #529: Total Expenses, Total Utilization, and Prescription Opioid Use, 2017. AHRQ.
Centers for Disease Control and Prevention. (February 11, 2026). Opioid Dispensing Rate Maps. CDC.
StatPearls Publishing. (October 6, 2024). Hydrocodone and Acetaminophen. StatPearls [Internet].
StatPearls Publishing. (February 29, 2024). Hydrocodone. StatPearls [Internet].
U.S. Food and Drug Administration. NORCO® Hydrocodone Bitartrate and Acetaminophen Tablets, USP. FDA.
Drug Enforcement Administration. HYDROCODONE (Trade Names: Vicodin®, Lortab®, Lorcet-HD®). DEA.
U.S. Food and Drug Administration. Vicodin. FDA.
Bailey CP, Connor M. (2013). Molecular Mechanisms of Opioid Receptor-Dependent Signaling and Tolerance. Annual Review of Pharmacology and Toxicology, 53, 451–471.
Frontiers. (June 23, 2025). Molecular and cellular basis of mu-opioid receptor signaling. Frontiers in Neuroscience. doi:10.3389/fnins.2025.1597922
Williams JT, Christie MJ, Manzoni O. (2005). Opioids: Cellular mechanisms of tolerance and physical dependence. Current Pharmaceutical Design, 11(31), 4099–4116.
University of Maryland School of Medicine. (2023). Structure of Opioid Receptors May Reveal How to Better Design Pain Relievers, Addiction Therapies. University of Maryland School of Medicine.
StatPearls Publishing. (June 8, 2024). Mu Receptors. StatPearls [Internet].
National Institute on Drug Abuse. (June 1, 2021). Prescription Opioids DrugFacts. NIDA.
Substance Abuse and Mental Health Services Administration. (June 9, 2023). SAMHSA’s National Helpline. SAMHSA.
PubMed. Chronic excessive acetaminophen use and liver damage. Annals of Internal Medicine.
University of Florida. Acetaminophen Hepatotoxicity and Acute Liver Failure. University of Florida.
U.S. Food and Drug Administration. (February 1, 2024). Don’t Overuse Acetaminophen. FDA.
StatPearls Publishing. (February 19, 2026). Acetaminophen Toxicity. StatPearls [Internet].
StatPearls Publishing. (January 22, 2025). Opioid Toxicity. StatPearls [Internet].
National Center for Biotechnology Information. Withdrawal Management. NCBI Bookshelf.
National Library of Medicine. (May 4, 2024). Opiate and opioid withdrawal. MedlinePlus.
Collins ED, Kleber HD, Whittington RA, Heitler NE. (August 2003). Newer approaches to opioid detoxification. Yale Journal of Biology and Medicine, 76(1), 51–55.
U.S. Food and Drug Administration. (December 26, 2024). Information about Medications for Opioid Use Disorder (MOUD). FDA.
Centers for Disease Control and Prevention. (August 12, 2024). Treatment of Opioid Use Disorder. CDC.
Blanco C, et al. (June 3, 2021). Therapeutic Approaches to Opioid Use Disorder: What is the Current Landscape?. American Journal of Psychiatry, 178(6), 521–530.
(November 12, 2024). A review of natural interventions in substance abuse treatment and recovery. Journal of Substance Use and Addiction Treatment.
State of Georgia. Subject 111-8-19 RULES AND REGULATIONS FOR DRUG ABUSE TREATMENT AND EDUCATION PROGRAMS. Georgia Secretary of State.